Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00772434 · ClinicalTrials.gov registry record
Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 412
- Enrollment target
NCT00772434: Completed study, sponsored by Rockefeller University.
NCT00772434 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 412 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00772434 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 412 participants
- Enrollment target
Study Summary
A wide variety of individuals are at risk for bleeding, but even though bleeding symptoms are common it is difficult to compare different people's symptoms. Recent research has found that carefully designed surveys can be used to calculate a bleeding score that is useful for diagnosing bleeding disorders, but normal individuals have not been specifically studied in large numbers with a comprehensive survey. Whether factors like race, ethnicity, age, sex, aspirin use, and previous trauma and surgery influence bleeding scores is also unknown. The primary goal of this study is to use a comprehensive computerized questionnaire to record the bleeding symptoms of normal individuals and then assess the range and severity of bleeding symptoms in this normal population. Secondary goals include determining whether race, ethnicity, age, sex, aspirin use, and previous trauma and surgery correlate with bleeding symptoms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 412 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-05 |
What the finished NCT00772434 record still lists
NCT00772434 is an observational study that tracks outcomes without assigning an intervention. The registered 412 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00772434 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00772434 about?
NCT00772434 is a clinical study titled "Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument". A wide variety of individuals are at risk for bleeding, but even though bleeding symptoms are common it is difficult to compare different people's symptoms. Recent research has found that carefully designed surveys can be used to calculate a bleeding score that is useful for diagnosing bleeding diso...
What is the current status of trial NCT00772434?
This trial is currently completed. The enrollment target is 412 participants. The study started on 2008-09. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT00772434?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05993689 · 412 participants · NA
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
- NCT06699212 · 412 participants · Phase 3
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia